WHITE PAPER
Subject Recruitment for the Consumerization of Clinical Trials in Asia Pacific
In a COVID-19 climate, there has been a huge shift in clinical trial management. Bespoke subject recruitment is a fundamental step to bring a trial to a prospective participant.
Jul 09, 2021
Download

The COVID-19 pandemic has brought changes to clinical trial management, accelerating the rise of decentralized virtual and hybrid clinical trials and increasing the need for bespoke, tailored approaches to subject recruitment. In Asia Pacific (APAC), increased competition for subjects and more stringent eligibility criteria coupled with highly differentiated regulatory frameworks are making it more challenging to solely depend on traditional, site-led recruitment models.

In collaboration with GSK Consumer Healthcare (GSKCH), this white paper provides a perspective to the on-ground realities in the post-pandemic world and a foundation for the strategies that will enable sponsors to thrive in the new environment. Alongside other case studies, the GSKCH topical pain relief medication feature case study does a deep dive into clinical trial recruitment challenges, such as stringent eligibility criteria, low subject interest, limited outreach channels and how, through close collaboration, these barriers can be overcome using a multi-pronged approach.

By building on the lessons of those studies, sponsors will be able to deploy bespoke solutions that are truly subject centric. Download to read more or click here to learn more about our Patient Recruitment Services (PRS) solution.

Contact Us